New CLSI Report Provides Guidance on MRSA Surveillance
As infections due to methicillin-resistant Staphylococcus aureus (MRSA) has climbed dramatically, so has the concern about the resultant morbidity and mortality in healthcare settings as well as in the community. Whether nosocomial or community acquired, MRSA is of concern to government agencies, healthcare providers and the public at large.
One strategy to reduce transmission in healthcare settings is to conduct active surveillance of patients admitted to healthcare settings for colonization and then placing such patients in contact isolation-with or without the adjunct of aggressive antimicrobial intervention.
Colonized patients are potential reservoirs of infection for themselves, other patients and healthcare workers, who might then further infect additional patients. What subset of patients should be tested? How wide should the surveillance net be cast? What measures should be taken with patients who are colonized? All these factors should be considered as part of any organizational surveillance program. A brand new CLSI report, titled Surveillance for Methicillin-Resistant Staphylococcus aureus: Principles, Practices, and Challenges; A Report (X07-R) addresses these questions and more.
Has your institution adopted MRSA surveillance? What's the process?